Related Experiment Video

Updated: Aug 12, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C virus-associated glomerulonephritis

C Stehman-Breen1, R Willson, C E Alpers

  • 1Division of Nephrology, University of Washington Medical Center, Seattle, USA.

Current Opinion in Nephrology and Hypertension
|May 1, 1995
PubMed

Insights

Hepatitis C virus (HCV) infection can cause kidney disease like glomerulonephritis. While interferon-alpha shows promise, optimal treatment for HCV-related kidney issues requires further research.

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease.
  • HCV is linked to extrahepatic manifestations, including cryoglobulinemia and glomerulonephritis.
  • Epidemiological data indicate HCV as a significant risk factor for cryoglobulinemic and type I membranoproliferative glomerulonephritis (MPGN).

Purpose of the Study:

  • To review the association between Hepatitis C virus (HCV) infection and glomerulonephritis.
  • To discuss the clinical presentation, pathogenesis, and treatment of HCV-associated MPGN.

Main Methods:

  • Review of epidemiological evidence and clinical data.
  • Analysis of laboratory findings in patients with HCV-associated MPGN.
  • Evaluation of treatment outcomes with interferon-alpha.

Main Results:

  • HCV-associated MPGN often presents with hypocomplementemia, rheumatoid factors, and cryoglobulinemia.
  • The proposed pathogenesis involves glomerular deposition of circulating HCV and anti-HCV antibodies.
  • Interferon-alpha therapy can improve proteinuria, reduce viral load, and stabilize renal function, but relapses are common.

Conclusions:

  • HCV is a significant risk factor for MPGN.
  • Interferon-alpha offers temporary benefits, but long-term treatment strategies for HCV-related kidney disease are still under investigation.
  • Optimal therapeutic approaches may involve modified interferon-alpha regimens or combination antiviral therapies.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...